1h Free Analyst Time
The global cancer biologics market is forecasted to grow by USD 68.00 billion during 2025-2030, accelerating at a CAGR of 8.2% during the forecast period. The report on the global cancer biologics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating prevalence of oncology indications and aging demographics, technological advancements in recombinant dna and antibody engineering, favorable regulatory frameworks and expedited approval pathways.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global cancer biologics market is segmented as below:
By Product
- Monoclonal antibodies
- Cell and gene therapy
- Vaccines
- Others
By Route Of Administration
- Injectable
- Oral
By Type
- Breast cancer
- Lung cancer
- Prostate cancer
- Colorectal cancer
- Others
By End-User
- Hospitals
- Specialized cancer centers
- Academic and research institutes
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
The report on the global cancer biologics market covers the following areas:
- Global cancer biologics market sizing
- Global cancer biologics market forecast
- Global cancer biologics market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Cancer Biologics Market 2020 - 2024
- Historic Market Size - Data Table on Global Cancer Biologics Market 2020 - 2024 ($ million)
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on global cancer biologics market
6.2 Impact of geopolitical conflicts on global cancer biologics market
6.2 Impact of geopolitical conflicts on global cancer biologics market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Product
8.1 Market segments
- Chart on Product - Market share 2025-2030 (%)
- Data Table on Product - Market share 2025-2030 (%)
- Chart on Comparison by Product
- Data Table on Comparison by Product
- Chart on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
- Data Table on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
- Chart on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
- Data Table on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
- Chart on Cell and gene therapy - Market size and forecast 2025-2030 ($ million)
- Data Table on Cell and gene therapy - Market size and forecast 2025-2030 ($ million)
- Chart on Cell and gene therapy - Year-over-year growth 2025-2030 (%)
- Data Table on Cell and gene therapy - Year-over-year growth 2025-2030 (%)
- Chart on Vaccines - Market size and forecast 2025-2030 ($ million)
- Data Table on Vaccines - Market size and forecast 2025-2030 ($ million)
- Chart on Vaccines - Year-over-year growth 2025-2030 (%)
- Data Table on Vaccines - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Route of Administration
9.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Injectable - Market size and forecast 2025-2030 ($ million)
- Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
- Chart on Injectable - Year-over-year growth 2025-2030 (%)
- Data Table on Injectable - Year-over-year growth 2025-2030 (%)
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
10 Market Segmentation by Type
10.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Breast cancer - Market size and forecast 2025-2030 ($ million)
- Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million)
- Chart on Breast cancer - Year-over-year growth 2025-2030 (%)
- Data Table on Breast cancer - Year-over-year growth 2025-2030 (%)
- Chart on Lung cancer - Market size and forecast 2025-2030 ($ million)
- Data Table on Lung cancer - Market size and forecast 2025-2030 ($ million)
- Chart on Lung cancer - Year-over-year growth 2025-2030 (%)
- Data Table on Lung cancer - Year-over-year growth 2025-2030 (%)
- Chart on Prostate cancer - Market size and forecast 2025-2030 ($ million)
- Data Table on Prostate cancer - Market size and forecast 2025-2030 ($ million)
- Chart on Prostate cancer - Year-over-year growth 2025-2030 (%)
- Data Table on Prostate cancer - Year-over-year growth 2025-2030 (%)
- Chart on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
- Data Table on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
- Chart on Colorectal cancer - Year-over-year growth 2025-2030 (%)
- Data Table on Colorectal cancer - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
11 Market Segmentation by End-user
11.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
- Chart on Hospitals - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
- Chart on Specialized cancer centers - Market size and forecast 2025-2030 ($ million)
- Data Table on Specialized cancer centers - Market size and forecast 2025-2030 ($ million)
- Chart on Specialized cancer centers - Year-over-year growth 2025-2030 (%)
- Data Table on Specialized cancer centers - Year-over-year growth 2025-2030 (%)
- Chart on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
- Data Table on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
- Chart on Academic and research institutes - Year-over-year growth 2025-2030 (%)
- Data Table on Academic and research institutes - Year-over-year growth 2025-2030 (%)
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
12 Customer Landscape
12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
13.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Taiwan - Market size and forecast 2025-2030 ($ million)
- Data Table on Taiwan - Market size and forecast 2025-2030 ($ million)
- Chart on Taiwan - Year-over-year growth 2025-2030 (%)
- Data Table on Taiwan - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Chart on Chile - Market size and forecast 2025-2030 ($ million)
- Data Table on Chile - Market size and forecast 2025-2030 ($ million)
- Chart on Chile - Year-over-year growth 2025-2030 (%)
- Data Table on Chile - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
14 Drivers, Challenges, and Opportunity
14.1 Market drivers
- Escalating prevalence of oncology indications and aging demographics
- Technological advancements in recombinant DNA and antibody engineering
- Favorable regulatory frameworks and expedited approval pathways
- High manufacturing costs and complex production processes
- Stringent regulatory hurdles and extended approval timelines
- Reimbursement complexities and substantial treatment costs
- Impact of drivers and challenges in 2025 and 2030
- Proliferation of personalized medicine and precision oncology
- Expansion of biosimilar adoption and market penetration
- Integration of AI and ML in drug discovery
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Segment focus
- SWOT
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Business segments
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- AstraZeneca Plc - Segment focus
- SWOT
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- CSL Ltd. - Overview
- CSL Ltd. - Business segments
- CSL Ltd. - Key offerings
- CSL Ltd. - Segment focus
- SWOT
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key news
- Eli Lilly and Co. - Key offerings
- SWOT
- Johnson and Johnson - Overview
- Johnson and Johnson - Business segments
- Johnson and Johnson - Key news
- Johnson and Johnson - Key offerings
- Johnson and Johnson - Segment focus
- SWOT
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Segment focus
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
17 Appendix
17.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 7: Executive Summary - Chart on Market Segmentation by Type
Exhibit 8: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Cancer Biologics Market 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Product Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Product - Market share 2025-2030 (%)
Exhibit 41: Data Table on Product - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Product
Exhibit 43: Data Table on Comparison by Product
Exhibit 44: Chart on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
Exhibit 45: Data Table on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
Exhibit 46: Chart on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Cell and gene therapy - Market size and forecast 2025-2030 ($ million)
Exhibit 49: Data Table on Cell and gene therapy - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Chart on Cell and gene therapy - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Cell and gene therapy - Year-over-year growth 2025-2030 (%)
Exhibit 52: Chart on Vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 53: Data Table on Vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 54: Chart on Vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 55: Data Table on Vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 56: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 60: Market opportunity by Product ($ million)
Exhibit 61: Data Table on Market opportunity by Product ($ million)
Exhibit 62: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 63: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 64: Chart on Comparison by Route of Administration
Exhibit 65: Data Table on Comparison by Route of Administration
Exhibit 66: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 67: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 68: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 69: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 70: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 74: Market opportunity by Route of Administration ($ million)
Exhibit 75: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 76: Chart on Type - Market share 2025-2030 (%)
Exhibit 77: Data Table on Type - Market share 2025-2030 (%)
Exhibit 78: Chart on Comparison by Type
Exhibit 79: Data Table on Comparison by Type
Exhibit 80: Chart on Breast cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 81: Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 82: Chart on Breast cancer - Year-over-year growth 2025-2030 (%)
Exhibit 83: Data Table on Breast cancer - Year-over-year growth 2025-2030 (%)
Exhibit 84: Chart on Lung cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 85: Data Table on Lung cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 86: Chart on Lung cancer - Year-over-year growth 2025-2030 (%)
Exhibit 87: Data Table on Lung cancer - Year-over-year growth 2025-2030 (%)
Exhibit 88: Chart on Prostate cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 89: Data Table on Prostate cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 90: Chart on Prostate cancer - Year-over-year growth 2025-2030 (%)
Exhibit 91: Data Table on Prostate cancer - Year-over-year growth 2025-2030 (%)
Exhibit 92: Chart on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 93: Data Table on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 94: Chart on Colorectal cancer - Year-over-year growth 2025-2030 (%)
Exhibit 95: Data Table on Colorectal cancer - Year-over-year growth 2025-2030 (%)
Exhibit 96: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 97: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 98: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 99: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 100: Market opportunity by Type ($ million)
Exhibit 101: Data Table on Market opportunity by Type ($ million)
Exhibit 102: Chart on End-user - Market share 2025-2030 (%)
Exhibit 103: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 104: Chart on Comparison by End-user
Exhibit 105: Data Table on Comparison by End-user
Exhibit 106: Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 107: Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Chart on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 109: Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 110: Chart on Specialized cancer centers - Market size and forecast 2025-2030 ($ million)
Exhibit 111: Data Table on Specialized cancer centers - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Chart on Specialized cancer centers - Year-over-year growth 2025-2030 (%)
Exhibit 113: Data Table on Specialized cancer centers - Year-over-year growth 2025-2030 (%)
Exhibit 114: Chart on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Data Table on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Chart on Academic and research institutes - Year-over-year growth 2025-2030 (%)
Exhibit 117: Data Table on Academic and research institutes - Year-over-year growth 2025-2030 (%)
Exhibit 118: Market opportunity by End-user ($ million)
Exhibit 119: Data Table on Market opportunity by End-user ($ million)
Exhibit 120: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 121: Chart on Market share by geography 2025-2030 (%)
Exhibit 122: Data Table on Market share by geography 2025-2030 (%)
Exhibit 123: Chart on Geographic comparison
Exhibit 124: Data Table on Geographic comparison
Exhibit 125: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on Regional Comparison - North America
Exhibit 130: Data Table on Regional Comparison - North America
Exhibit 131: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 132: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 133: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 134: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 135: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 136: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 137: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 138: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 139: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 140: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 141: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 142: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 143: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 144: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 145: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 146: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 147: Chart on Regional Comparison - Europe
Exhibit 148: Data Table on Regional Comparison - Europe
Exhibit 149: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 166: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 167: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 168: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 169: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 170: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 171: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 172: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 173: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 174: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 175: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 176: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 177: Chart on Regional Comparison - Asia
Exhibit 178: Data Table on Regional Comparison - Asia
Exhibit 179: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 200: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 201: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 204: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 205: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 206: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 207: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 208: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 209: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 229: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 230: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 231: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 232: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 233: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 234: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 235: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 236: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 237: Chart on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 238: Data Table on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 239: Chart on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 240: Data Table on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 241: Market opportunity by geography ($ million)
Exhibit 242: Data Tables on Market opportunity by geography ($ million)
Exhibit 243: Impact of drivers and challenges in 2025 and 2030
Exhibit 244: Overview on criticality of inputs and factors of differentiation
Exhibit 245: Overview on factors of disruption
Exhibit 246: Impact of key risks on business
Exhibit 247: Companies covered
Exhibit 248: Company ranking index
Exhibit 249: Matrix on companies position and classification
Exhibit 250: AbbVie Inc. - Overview
Exhibit 251: AbbVie Inc. - Business segments
Exhibit 252: AbbVie Inc. - Key news
Exhibit 253: AbbVie Inc. - Key offerings
Exhibit 254: AbbVie Inc. - Segment focus
Exhibit 255: SWOT
Exhibit 256: Amgen Inc. - Overview
Exhibit 257: Amgen Inc. - Product / Service
Exhibit 258: Amgen Inc. - Key news
Exhibit 259: Amgen Inc. - Key offerings
Exhibit 260: SWOT
Exhibit 261: AstraZeneca Plc - Overview
Exhibit 262: AstraZeneca Plc - Business segments
Exhibit 263: AstraZeneca Plc - Key news
Exhibit 264: AstraZeneca Plc - Key offerings
Exhibit 265: AstraZeneca Plc - Segment focus
Exhibit 266: SWOT
Exhibit 267: Bayer AG - Overview
Exhibit 268: Bayer AG - Business segments
Exhibit 269: Bayer AG - Key news
Exhibit 270: Bayer AG - Key offerings
Exhibit 271: Bayer AG - Segment focus
Exhibit 272: SWOT
Exhibit 273: Bristol Myers Squibb Co. - Overview
Exhibit 274: Bristol Myers Squibb Co. - Product / Service
Exhibit 275: Bristol Myers Squibb Co. - Key news
Exhibit 276: Bristol Myers Squibb Co. - Key offerings
Exhibit 277: SWOT
Exhibit 278: Cipla Inc. - Overview
Exhibit 279: Cipla Inc. - Business segments
Exhibit 280: Cipla Inc. - Key news
Exhibit 281: Cipla Inc. - Key offerings
Exhibit 282: Cipla Inc. - Segment focus
Exhibit 283: SWOT
Exhibit 284: CSL Ltd. - Overview
Exhibit 285: CSL Ltd. - Business segments
Exhibit 286: CSL Ltd. - Key offerings
Exhibit 287: CSL Ltd. - Segment focus
Exhibit 288: SWOT
Exhibit 289: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 290: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 291: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 292: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 293: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 294: SWOT
Exhibit 295: Eli Lilly and Co. - Overview
Exhibit 296: Eli Lilly and Co. - Product / Service
Exhibit 297: Eli Lilly and Co. - Key news
Exhibit 298: Eli Lilly and Co. - Key offerings
Exhibit 299: SWOT
Exhibit 300: Johnson and Johnson - Overview
Exhibit 301: Johnson and Johnson - Business segments
Exhibit 302: Johnson and Johnson - Key news
Exhibit 303: Johnson and Johnson - Key offerings
Exhibit 304: Johnson and Johnson - Segment focus
Exhibit 305: SWOT
Exhibit 306: Lupin Ltd. - Overview
Exhibit 307: Lupin Ltd. - Business segments
Exhibit 308: Lupin Ltd. - Key news
Exhibit 309: Lupin Ltd. - Key offerings
Exhibit 310: Lupin Ltd. - Segment focus
Exhibit 311: SWOT
Exhibit 312: Merck and Co. Inc. - Overview
Exhibit 313: Merck and Co. Inc. - Business segments
Exhibit 314: Merck and Co. Inc. - Key news
Exhibit 315: Merck and Co. Inc. - Key offerings
Exhibit 316: Merck and Co. Inc. - Segment focus
Exhibit 317: SWOT
Exhibit 318: Novartis AG - Overview
Exhibit 319: Novartis AG - Business segments
Exhibit 320: Novartis AG - Key news
Exhibit 321: Novartis AG - Key offerings
Exhibit 322: Novartis AG - Segment focus
Exhibit 323: SWOT
Exhibit 324: Pfizer Inc. - Overview
Exhibit 325: Pfizer Inc. - Business segments
Exhibit 326: Pfizer Inc. - Key news
Exhibit 327: Pfizer Inc. - Key offerings
Exhibit 328: Pfizer Inc. - Segment focus
Exhibit 329: SWOT
Exhibit 330: Sanofi SA - Overview
Exhibit 331: Sanofi SA - Business segments
Exhibit 332: Sanofi SA - Key news
Exhibit 333: Sanofi SA - Key offerings
Exhibit 334: Sanofi SA - Segment focus
Exhibit 335: SWOT
Exhibit 336: Inclusions checklist
Exhibit 337: Exclusions checklist
Exhibit 338: Currency conversion rates for US$
Exhibit 339: Research methodology
Exhibit 340: Information sources
Exhibit 341: Data validation
Exhibit 342: Validation techniques employed for market sizing
Exhibit 343: Data synthesis
Exhibit 344: 360 degree market analysis
Exhibit 345: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 7: Executive Summary - Chart on Market Segmentation by Type
Exhibit 8: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Cancer Biologics Market 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Product Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Product - Market share 2025-2030 (%)
Exhibit 41: Data Table on Product - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Product
Exhibit 43: Data Table on Comparison by Product
Exhibit 44: Chart on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
Exhibit 45: Data Table on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
Exhibit 46: Chart on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Cell and gene therapy - Market size and forecast 2025-2030 ($ million)
Exhibit 49: Data Table on Cell and gene therapy - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Chart on Cell and gene therapy - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Cell and gene therapy - Year-over-year growth 2025-2030 (%)
Exhibit 52: Chart on Vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 53: Data Table on Vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 54: Chart on Vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 55: Data Table on Vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 56: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 60: Market opportunity by Product ($ million)
Exhibit 61: Data Table on Market opportunity by Product ($ million)
Exhibit 62: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 63: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 64: Chart on Comparison by Route of Administration
Exhibit 65: Data Table on Comparison by Route of Administration
Exhibit 66: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 67: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 68: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 69: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 70: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 74: Market opportunity by Route of Administration ($ million)
Exhibit 75: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 76: Chart on Type - Market share 2025-2030 (%)
Exhibit 77: Data Table on Type - Market share 2025-2030 (%)
Exhibit 78: Chart on Comparison by Type
Exhibit 79: Data Table on Comparison by Type
Exhibit 80: Chart on Breast cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 81: Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 82: Chart on Breast cancer - Year-over-year growth 2025-2030 (%)
Exhibit 83: Data Table on Breast cancer - Year-over-year growth 2025-2030 (%)
Exhibit 84: Chart on Lung cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 85: Data Table on Lung cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 86: Chart on Lung cancer - Year-over-year growth 2025-2030 (%)
Exhibit 87: Data Table on Lung cancer - Year-over-year growth 2025-2030 (%)
Exhibit 88: Chart on Prostate cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 89: Data Table on Prostate cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 90: Chart on Prostate cancer - Year-over-year growth 2025-2030 (%)
Exhibit 91: Data Table on Prostate cancer - Year-over-year growth 2025-2030 (%)
Exhibit 92: Chart on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 93: Data Table on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 94: Chart on Colorectal cancer - Year-over-year growth 2025-2030 (%)
Exhibit 95: Data Table on Colorectal cancer - Year-over-year growth 2025-2030 (%)
Exhibit 96: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 97: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 98: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 99: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 100: Market opportunity by Type ($ million)
Exhibit 101: Data Table on Market opportunity by Type ($ million)
Exhibit 102: Chart on End-user - Market share 2025-2030 (%)
Exhibit 103: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 104: Chart on Comparison by End-user
Exhibit 105: Data Table on Comparison by End-user
Exhibit 106: Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 107: Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Chart on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 109: Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 110: Chart on Specialized cancer centers - Market size and forecast 2025-2030 ($ million)
Exhibit 111: Data Table on Specialized cancer centers - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Chart on Specialized cancer centers - Year-over-year growth 2025-2030 (%)
Exhibit 113: Data Table on Specialized cancer centers - Year-over-year growth 2025-2030 (%)
Exhibit 114: Chart on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Data Table on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Chart on Academic and research institutes - Year-over-year growth 2025-2030 (%)
Exhibit 117: Data Table on Academic and research institutes - Year-over-year growth 2025-2030 (%)
Exhibit 118: Market opportunity by End-user ($ million)
Exhibit 119: Data Table on Market opportunity by End-user ($ million)
Exhibit 120: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 121: Chart on Market share by geography 2025-2030 (%)
Exhibit 122: Data Table on Market share by geography 2025-2030 (%)
Exhibit 123: Chart on Geographic comparison
Exhibit 124: Data Table on Geographic comparison
Exhibit 125: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on Regional Comparison - North America
Exhibit 130: Data Table on Regional Comparison - North America
Exhibit 131: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 132: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 133: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 134: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 135: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 136: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 137: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 138: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 139: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 140: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 141: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 142: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 143: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 144: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 145: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 146: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 147: Chart on Regional Comparison - Europe
Exhibit 148: Data Table on Regional Comparison - Europe
Exhibit 149: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 166: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 167: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 168: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 169: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 170: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 171: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 172: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 173: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 174: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 175: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 176: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 177: Chart on Regional Comparison - Asia
Exhibit 178: Data Table on Regional Comparison - Asia
Exhibit 179: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 200: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 201: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 204: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 205: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 206: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 207: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 208: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 209: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 229: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 230: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 231: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 232: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 233: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 234: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 235: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 236: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 237: Chart on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 238: Data Table on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 239: Chart on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 240: Data Table on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 241: Market opportunity by geography ($ million)
Exhibit 242: Data Tables on Market opportunity by geography ($ million)
Exhibit 243: Impact of drivers and challenges in 2025 and 2030
Exhibit 244: Overview on criticality of inputs and factors of differentiation
Exhibit 245: Overview on factors of disruption
Exhibit 246: Impact of key risks on business
Exhibit 247: Companies covered
Exhibit 248: Company ranking index
Exhibit 249: Matrix on companies position and classification
Exhibit 250: AbbVie Inc. - Overview
Exhibit 251: AbbVie Inc. - Business segments
Exhibit 252: AbbVie Inc. - Key news
Exhibit 253: AbbVie Inc. - Key offerings
Exhibit 254: AbbVie Inc. - Segment focus
Exhibit 255: SWOT
Exhibit 256: Amgen Inc. - Overview
Exhibit 257: Amgen Inc. - Product / Service
Exhibit 258: Amgen Inc. - Key news
Exhibit 259: Amgen Inc. - Key offerings
Exhibit 260: SWOT
Exhibit 261: AstraZeneca Plc - Overview
Exhibit 262: AstraZeneca Plc - Business segments
Exhibit 263: AstraZeneca Plc - Key news
Exhibit 264: AstraZeneca Plc - Key offerings
Exhibit 265: AstraZeneca Plc - Segment focus
Exhibit 266: SWOT
Exhibit 267: Bayer AG - Overview
Exhibit 268: Bayer AG - Business segments
Exhibit 269: Bayer AG - Key news
Exhibit 270: Bayer AG - Key offerings
Exhibit 271: Bayer AG - Segment focus
Exhibit 272: SWOT
Exhibit 273: Bristol Myers Squibb Co. - Overview
Exhibit 274: Bristol Myers Squibb Co. - Product / Service
Exhibit 275: Bristol Myers Squibb Co. - Key news
Exhibit 276: Bristol Myers Squibb Co. - Key offerings
Exhibit 277: SWOT
Exhibit 278: Cipla Inc. - Overview
Exhibit 279: Cipla Inc. - Business segments
Exhibit 280: Cipla Inc. - Key news
Exhibit 281: Cipla Inc. - Key offerings
Exhibit 282: Cipla Inc. - Segment focus
Exhibit 283: SWOT
Exhibit 284: CSL Ltd. - Overview
Exhibit 285: CSL Ltd. - Business segments
Exhibit 286: CSL Ltd. - Key offerings
Exhibit 287: CSL Ltd. - Segment focus
Exhibit 288: SWOT
Exhibit 289: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 290: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 291: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 292: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 293: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 294: SWOT
Exhibit 295: Eli Lilly and Co. - Overview
Exhibit 296: Eli Lilly and Co. - Product / Service
Exhibit 297: Eli Lilly and Co. - Key news
Exhibit 298: Eli Lilly and Co. - Key offerings
Exhibit 299: SWOT
Exhibit 300: Johnson and Johnson - Overview
Exhibit 301: Johnson and Johnson - Business segments
Exhibit 302: Johnson and Johnson - Key news
Exhibit 303: Johnson and Johnson - Key offerings
Exhibit 304: Johnson and Johnson - Segment focus
Exhibit 305: SWOT
Exhibit 306: Lupin Ltd. - Overview
Exhibit 307: Lupin Ltd. - Business segments
Exhibit 308: Lupin Ltd. - Key news
Exhibit 309: Lupin Ltd. - Key offerings
Exhibit 310: Lupin Ltd. - Segment focus
Exhibit 311: SWOT
Exhibit 312: Merck and Co. Inc. - Overview
Exhibit 313: Merck and Co. Inc. - Business segments
Exhibit 314: Merck and Co. Inc. - Key news
Exhibit 315: Merck and Co. Inc. - Key offerings
Exhibit 316: Merck and Co. Inc. - Segment focus
Exhibit 317: SWOT
Exhibit 318: Novartis AG - Overview
Exhibit 319: Novartis AG - Business segments
Exhibit 320: Novartis AG - Key news
Exhibit 321: Novartis AG - Key offerings
Exhibit 322: Novartis AG - Segment focus
Exhibit 323: SWOT
Exhibit 324: Pfizer Inc. - Overview
Exhibit 325: Pfizer Inc. - Business segments
Exhibit 326: Pfizer Inc. - Key news
Exhibit 327: Pfizer Inc. - Key offerings
Exhibit 328: Pfizer Inc. - Segment focus
Exhibit 329: SWOT
Exhibit 330: Sanofi SA - Overview
Exhibit 331: Sanofi SA - Business segments
Exhibit 332: Sanofi SA - Key news
Exhibit 333: Sanofi SA - Key offerings
Exhibit 334: Sanofi SA - Segment focus
Exhibit 335: SWOT
Exhibit 336: Inclusions checklist
Exhibit 337: Exclusions checklist
Exhibit 338: Currency conversion rates for US$
Exhibit 339: Research methodology
Exhibit 340: Information sources
Exhibit 341: Data validation
Exhibit 342: Validation techniques employed for market sizing
Exhibit 343: Data synthesis
Exhibit 344: 360 degree market analysis
Exhibit 345: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global cancer biologics market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, Biocon Ltd., Bristol Myers Squibb Co., Celltrion Co. Ltd., Cipla Inc., CSL Ltd., Dr. Reddys Laboratories Ltd., Eisai Co. Ltd., Eli Lilly and Co., Genentech Inc., Jazz Pharmaceuticals Plc, Johnson and Johnson, Kite Pharma Inc., Lupin Ltd., Merck and Co. Inc., Novartis AG, Organon and Co., Pfizer Inc., Sanofi SA.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is proliferation of personalized medicine and precision oncology."
According to the report, one of the major drivers for this market is the escalating prevalence of oncology indications and aging demographics.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Bayer AG
- Biocon Ltd.
- Bristol Myers Squibb Co.
- Celltrion Co. Ltd.
- Cipla Inc.
- CSL Ltd.
- Dr. Reddys Laboratories Ltd.
- Eisai Co. Ltd.
- Eli Lilly and Co.
- Genentech Inc.
- Jazz Pharmaceuticals Plc
- Johnson and Johnson
- Kite Pharma Inc.
- Lupin Ltd.
- Merck and Co. Inc.
- Novartis AG
- Organon and Co.
- Pfizer Inc.
- Sanofi SA
